The Food and Drug Administration has approved bemotrizinol as a new sunscreen ingredient, marking the first time in 25 years that American consumers will have access to a new chemical option for sun protection.

Bemotrizinol has been widely used in sunscreen products in other countries for decades, but had not previously received approval for use in the United States. The approval represents a significant development in the American sunscreen market, which has seen limited innovation in active ingredients since the late 1990s.

The FDA's approval process for new sunscreen ingredients has historically been lengthy and complex, requiring extensive safety and efficacy data. The agency must evaluate both the protective benefits of new ingredients and their potential health risks before granting approval.

With this approval, American sunscreen manufacturers will now have the option to incorporate bemotrizinol into their formulations, potentially offering consumers new choices for sun protection products that have been available internationally for years.